These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 4954699)

  • 41. An ergot alkaloid preparation (hydergine) versus placebo for treatment of symptoms of cerebrovascular insufficiency: double-blind study.
    Jennings WG
    J Am Geriatr Soc; 1972 Aug; 20(8):407-12. PubMed ID: 4626496
    [No Abstract]   [Full Text] [Related]  

  • 42. Use of an ergot preparation (hydergine) in the convalescent phase of stroke.
    Bochner F; Eadie MJ; Tyrer JH
    J Am Geriatr Soc; 1973 Jan; 21(1):10-7. PubMed ID: 4630036
    [No Abstract]   [Full Text] [Related]  

  • 43. Hydergine effect on cerebral circulation in cerebrovascular disease.
    McHenry LC; Jaffe ME; Kawamura J; Goldberg HI
    J Neurol Sci; 1971 Aug; 13(4):475-81. PubMed ID: 4998934
    [No Abstract]   [Full Text] [Related]  

  • 44. An ergot preparation (hydergine) in the treatment of cerebrovascular disorders in the geriatric patient: double-blind study.
    Ditch M; Kelly FJ; Resnick O
    J Am Geriatr Soc; 1971 Mar; 19(3):208-17. PubMed ID: 4998602
    [No Abstract]   [Full Text] [Related]  

  • 45. [Therapy of cerebral ictus yesterday and today].
    Giorgini R
    Minerva Med; 1974 Mar; 65(24):1316-21. PubMed ID: 4133959
    [No Abstract]   [Full Text] [Related]  

  • 46. [Headaches in patients with vascular deficiency and their treatment with a raubasine-dihydroergocristine association].
    Henry P
    Bord Med; 1972 Nov; 5(18):2531-4. PubMed ID: 4196611
    [No Abstract]   [Full Text] [Related]  

  • 47. [Effect of raubasine and dihydroergocristine on arteriosclerotic and hypertensive cerebral diseases].
    Klein K
    Vasa; 1973; 2(4):409-14. PubMed ID: 4202492
    [No Abstract]   [Full Text] [Related]  

  • 48. An ergot alkaloid preparation (Hydergine) versus papaverine in treating common complaints of the aged: double-blind study.
    Bazo AJ
    J Am Geriatr Soc; 1973 Feb; 21(2):63-71. PubMed ID: 4631704
    [No Abstract]   [Full Text] [Related]  

  • 49. Electroencephalogram and ergot alkaloids.
    Venn RD
    Postgrad Med J; 1976; 52suppl 1():55-6. PubMed ID: 822408
    [No Abstract]   [Full Text] [Related]  

  • 50. [Vergebro-basilar insufficiency. Prevention of transient ischemic accidents with hydergine].
    Augustin P; Lechevalier B
    Therapeutique; 1970 May; 46(5):543-6. PubMed ID: 4988090
    [No Abstract]   [Full Text] [Related]  

  • 51. [Combined treatment with hydergine and neuroleptics in mental disorders of old age].
    Bukowczyk A; Wasik A; Horodnicki J
    Psychiatr Pol; 1969; 3(3):327-32. PubMed ID: 4980081
    [No Abstract]   [Full Text] [Related]  

  • 52. [Therapy of acute cerebrovascular insufficiency].
    Volles E
    Dtsch Med Wochenschr; 1973 Jan; 98(3):123. PubMed ID: 4630687
    [No Abstract]   [Full Text] [Related]  

  • 53. [Treatment of elderly patients with an effective anxiolytic drug combination].
    Hadjwasiri H
    Schweiz Rundsch Med Prax; 1973 Nov; 62(44):1383-9. PubMed ID: 4202443
    [No Abstract]   [Full Text] [Related]  

  • 54. Sinus bradycardia following treatment with hydergine for cerebrovascular insufficiency.
    Dcayley AC; Macpherson A; Wedgwood J
    Br Med J; 1975 Nov; 4(5993):384-5. PubMed ID: 811310
    [No Abstract]   [Full Text] [Related]  

  • 55. [Treatment of patients with cerebral and diffuse arteriosclerosis with hydergine].
    Avena G
    Hospital (Rio J); 1970 Sep; 78(3):901-28. PubMed ID: 4994595
    [No Abstract]   [Full Text] [Related]  

  • 56. Influence of treatment on symptomatology and correlated electroencephalographic (EEG) changes in the aged.
    Arrigo A; Braun P; Kauchtschischwili GM; Moglia A; Tartara A
    Curr Ther Res Clin Exp; 1973 Jul; 15(7):417-26. PubMed ID: 4198303
    [No Abstract]   [Full Text] [Related]  

  • 57. [Therapeutic effects of hydergine in mental disorders in the involutional age].
    Bonasera N; Smorto M; Scialfa G
    Osp Psichiatr; 1968; 36(1):75-87. PubMed ID: 4988290
    [No Abstract]   [Full Text] [Related]  

  • 58. [On the behavior of cerebrovascular resistance under the influence of sympatholytics].
    Klein K; Siedek H
    Wien Med Wochenschr; 1966 Jan; 116(1):20-2. PubMed ID: 4962461
    [No Abstract]   [Full Text] [Related]  

  • 59. [How to treat a stroke].
    Arné L
    J Med Bord; 1967 Jun; 144(6):869-73. PubMed ID: 4980447
    [No Abstract]   [Full Text] [Related]  

  • 60. [Fatigue and tensional labilities].
    Blanc P
    Schweiz Rundsch Med Prax; 1970 Nov; 59(47):1654-60. PubMed ID: 4997753
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.